90 related articles for article (PubMed ID: 19810816)
1. IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
Garat A; Cauffiez C; Hamdan-Khalil R; Glowacki F; Devos A; Leclerc J; Lionet A; Allorge D; Lo-Guidice JM; Broly F
Genet Test Mol Biomarkers; 2009 Dec; 13(6):841-7. PubMed ID: 19810816
[TBL] [Abstract][Full Text] [Related]
2. Inter-ethnic variability of three functional polymorphisms affecting the IMPDH2 gene.
Garat A; Cardenas CL; Lionet A; Devos A; Glowacki F; Kenani A; Migot-Nabias F; Allorge D; Lo-Guidice JM; Broly F; Cauffiez C
Mol Biol Rep; 2011 Nov; 38(8):5185-8. PubMed ID: 21181270
[TBL] [Abstract][Full Text] [Related]
3. An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
Winnicki W; Weigel G; Sunder-Plassmann G; Bajari T; Winter B; Herkner H; Sengoelge G
Pharmacogenomics J; 2010 Feb; 10(1):70-6. PubMed ID: 19770842
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
[TBL] [Abstract][Full Text] [Related]
5. Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
Thomas EC; Gunter JH; Webster JA; Schieber NL; Oorschot V; Parton RG; Whitehead JP
PLoS One; 2012; 7(12):e51096. PubMed ID: 23236438
[TBL] [Abstract][Full Text] [Related]
6. Interpopulation variation frequency of human inosine 5'-monophosphate dehydrogenase type II (IMPDH2) genetic polymorphisms.
Mohamed MF; Frye RF; Langaee TY
Genet Test; 2008 Dec; 12(4):513-6. PubMed ID: 18976158
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte counts in kidney allograft recipients are associated with IMPDH2 3757T>C gene polymorphism.
Pazik J; Ołdak M; Podgórska M; Lewandowski Z; Sitarek E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
Transplant Proc; 2011 Oct; 43(8):2943-5. PubMed ID: 21996196
[TBL] [Abstract][Full Text] [Related]
8. IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance.
Roberts RL; Gearry RB; Barclay ML; Kennedy MA
Pharmacogenomics J; 2007 Oct; 7(5):312-7. PubMed ID: 17001353
[TBL] [Abstract][Full Text] [Related]
9. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
[TBL] [Abstract][Full Text] [Related]
10. Inosine monophosphate dehydrogenase expression: transcriptional regulation of the type I and type II genes.
Zimmermann A; Gu JJ; Spychala J; Mitchell BS
Adv Enzyme Regul; 1996; 36():75-84. PubMed ID: 8869741
[TBL] [Abstract][Full Text] [Related]
11. Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy.
Liao LX; Song XM; Wang LC; Lv HN; Chen JF; Liu D; Fu G; Zhao MB; Jiang Y; Zeng KW; Tu PF
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5986-E5994. PubMed ID: 28674004
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells.
Fellenberg J; Kunz P; Sähr H; Depeweg D
PLoS One; 2010 Aug; 5(8):e12179. PubMed ID: 20808934
[TBL] [Abstract][Full Text] [Related]
13. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family.
Manna PR; Dyson MT; Eubank DW; Clark BJ; Lalli E; Sassone-Corsi P; Zeleznik AJ; Stocco DM
Mol Endocrinol; 2002 Jan; 16(1):184-99. PubMed ID: 11773448
[TBL] [Abstract][Full Text] [Related]
14. Novel polymorphisms in UTR and coding region of inducible heat shock protein 70.1 gene in tropically adapted Indian zebu cattle (Bos indicus) and riverine buffalo (Bubalus bubalis).
Sodhi M; Mukesh M; Kishore A; Mishra BP; Kataria RS; Joshi BK
Gene; 2013 Sep; 527(2):606-15. PubMed ID: 23792016
[TBL] [Abstract][Full Text] [Related]
15. Expression of IMPDH1 and IMPDH2 after transplantation and initiation of immunosuppression.
Bremer S; Mandla R; Vethe NT; Rasmussen I; Rootwelt H; Line PD; Midtvedt K; Bergan S
Transplantation; 2008 Jan; 85(1):55-61. PubMed ID: 18192912
[TBL] [Abstract][Full Text] [Related]
16. IMPDH dysregulation in disease: a mini review.
Burrell AL; Kollman JM
Biochem Soc Trans; 2022 Feb; 50(1):71-82. PubMed ID: 35191957
[TBL] [Abstract][Full Text] [Related]
17. Identification of cis-elements mediating the stimulation of rat insulin-like growth factor-binding protein-1 promoter activity by dexamethasone, cyclic adenosine 3',5'-monophosphate, and phorbol esters, and inhibition by insulin.
Suh DS; Ooi GT; Rechler MM
Mol Endocrinol; 1994 Jun; 8(6):794-805. PubMed ID: 7523864
[TBL] [Abstract][Full Text] [Related]
18. IMPDH2 forms spots at branching sites and distal ends of astrocyte stem processes.
Toyoda S; Handa T; Yong H; Takahashi H; Shiwaku H
Genes Cells; 2024 Feb; 29(2):150-158. PubMed ID: 38009721
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters.
Gu JJ; Spychala J; Mitchell BS
J Biol Chem; 1997 Feb; 272(7):4458-66. PubMed ID: 9020170
[TBL] [Abstract][Full Text] [Related]
20. IMPDH1 retinal variants control filament architecture to tune allosteric regulation.
Burrell AL; Nie C; Said M; Simonet JC; Fernández-Justel D; Johnson MC; Quispe J; Buey RM; Peterson JR; Kollman JM
Nat Struct Mol Biol; 2022 Jan; 29(1):47-58. PubMed ID: 35013599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
